Skip to main content
. 2022 May;12(5):2917–2931. doi: 10.21037/qims-21-912

Table 2. The demographic and clinical characteristics of pGGNs in the primary and validation cohorts.

Characteristics Primary cohort (n=160) Validation cohort (n=63)
AIS/MIA (n=96) IA (n=64) P value AIS/MIA (n=39) IA (n=24) P value
Gender 0.012 0.256
   Male 25 29 8 8
   Female 71 35 31 16
Age (years) 50.3±10.8 54.3±9.5 0.016 50.3±13.0 53.2±15.8 0.423
Lobe 0.287 0.018
   Left upper lobe 30 14 15 5
   Left lower lobe 9 6 3 6
   Right upper lobe 39 33 18 6
   Right middle lobe 3 5 1 1
   Right lower lobe 15 6 2 6
Shape 0.044 0.185
   Round/oval 59 29 29 14
   Irregular 37 35 10 10
Margin 0.024 0.999
   Smooth 18 4 1 0
   Coarse 78 60 38 24
Interface 0.431 0.145
   Clear 42 24 17 15
   Blurry 54 40 22 9
Lobulation 0.001 0.256
   No 91 50 31 16
   Yes 5 14 8 8
Spiculation 0.703 0.141
   No 91 62 39 22
   Yes 5 2 0 2
Pleural indentation 0.073 0.045
   No 74 41 33 15
   Yes 22 23 6 9
Air bronchogram <0.001 0.721
   No 90 47 34 20
   Yes 6 17 5 4
Vacuole 0.007 0.049
   No 64 29 29 12
   Yes 32 35 10 12
Vessel type <0.001 <0.001
   Type I/II 77 10 32 3
   Type III/IV 19 54 7 21
Diameter (mm) 8.1±2.9 12.1±4.4 <0.001 7.1±2.4 10.8±4.3 <0.001
Volume (mm3) 509.4±399.3 1,609.5±1,874.9 <0.001 409.5±418.7 1,347.5±1,505.0 <0.001
Attenuation (HU) −663.1±63.8 −639.7±73.1 0.033 −673.8±57.4 −630.4±65.5 0.008
FS diagnosis <0.001 <0.001
   AIS/MIA 86 10 38 2
   IA 10 54 1 22
Surgical method <0.001 0.015
   Sublobar resection 80 32 31 12
   Lobectomy 16 32 8 12

Age, diameter, volume, and attenuation are shown in mean ± standard deviation, and the other data are the number of nodules. pGGNs, pure ground-glass nodules; AIS, adenocarcinoma in situ; MIA, minimally invasive adenocarcinoma; IA, invasive adenocarcinoma; FS, frozen section.